-
Wednesday's Biotech Stocks Trading
Thursday, September 8, 2011 - 12:27pm | 647Point Roberts, WA - September 9, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for September 07, 2011. Aethlon Medical, Inc. (OTC: AEMD) closed lower by 3.03% to $0.0640 on volume of 164K shares...
-
SIGA Trial Verdict Pending, Could Send Shares Higher
Friday, August 19, 2011 - 10:35am | 517A long awaited trial verdict for SIGA Technologies (NASDAQ: SIGA) is poised to be revealed in the coming weeks, as investors are eager to see whether the company will hold on to exclusive rights for its lead drug, ST-246. ST-246 is the world's first treatment for smallpox, a potential bioterrism...
-
Friday's Biotech/Pharma Stocks Trading
Monday, August 15, 2011 - 11:48am | 1475Point Roberts, WA - August 15, 2011 - Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks reports on trading and recent news for companies providing novel approaches to cancer therapy . In a roller coaster market of trading last week,...
-
Biotech/Pharma Stocks Trading News Alert: Aethlon Medical, OXiGENE, Adventrix, Chelsea Therapeutics, Exelixis
Wednesday, August 10, 2011 - 12:39pm | 1510Point Roberts, WA - August 10, 2011- Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for biotech and pharma stocks trading August 9th. Yesterday's trading session saw gains for investors in a very volatile...
-
Biotech Investor Alert; BioSante Rebounds, Trading up over 14%
Tuesday, August 9, 2011 - 3:34pm | 1245Point Roberts, WA, LINCOLNSHIRE, Ill - August 9, 2011 - Investorideas.com, a leader in sector stock research for independent investors , issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for August 9 th. The stock has bounced back as high as $2...
-
Mr. Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Discusses the Future of LibiGel® Following Closing of $48 Million Offering
Monday, August 8, 2011 - 10:52am | 1241Point Roberts, WA, LINCOLNSHIRE, Ill - August 8, 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features an exclusive Q&A interview with Mr. Stephen M. Simes, President and Chief Executive...
-
Biotech and Pharma News; BioSante Pharmaceuticals Closes $48.0 Million Public Offering of Common Stock
Wednesday, August 3, 2011 - 2:50pm | 1029LINCOLNSHIRE, Ill. - August 3, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the closing of its underwritten public offering of 16.0 million shares of common stock at a public offering price of $3.00 per share, for total gross proceeds of $48.0...
-
Biotech and Pharma News; BioSante Pharmaceuticals Prices Public Offering of Common Stock
Thursday, July 28, 2011 - 10:47am | 994LINCOLNSHIRE, Ill. - July 28, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the pricing of its previously announced underwritten public offering of 16.0 million shares of its common stock, offered at a price of $3.00 per share to the public. The...
-
Pharma News; BioSante Pharmaceuticals Reports Second Quarter 2011 Financial Results
Tuesday, July 26, 2011 - 1:48pm | 520LINCOLNSHIRE, Ill. - July 26, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced its financial results for the second quarter of 2011. The Company's cash and cash equivalents as of June 30, 2011 were approximately $37.1 million. BioSante incurred a...
-
Biotech/Pharma Trading News Alert for BioSante
Friday, July 22, 2011 - 12:39pm | 1028Point Roberts, WA, LINCOLNSHIRE, Ill - July 22, 2011 - Investorideas.com, a leader in sector stock research for independent investors , issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for July 22 nd . The stock traded as high as $3.73 on July...
-
Pharma and Biotech News; BioSante Pharmaceuticals Signs Melanoma Vaccine License
Thursday, July 21, 2011 - 11:25am | 1051LINCOLNSHIRE, Ill. - July 21, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening...
-
Biotech/Pharma Stocks Investor News Alert
Wednesday, July 20, 2011 - 11:57am | 1445Point Roberts, WA - July 20, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for July 19, 2011. Biotech/Pharma Sector Snapshot Trading July 19 th Aethlon Medical (OTCBB: AEMD) traded lower by 0.0041...
-
Pharma Stock News; BioSante Pharmaceuticals Announces Management Team Addition
Monday, July 18, 2011 - 12:13pm | 1056LINCOLNSHIRE, Ill. - July 18, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), today announced the appointment of Sandra Croak-Brossman, MS, Ph.D., as Vice President, Regulatory Affairs and Quality Assurance, and Patricia M. Adams, MS as Vice President, Human...
-
Biotech/Medical Technology Stock News; Aethlon Medical Releases Shareholder Letter
Friday, July 15, 2011 - 2:26pm | 1041SAN DIEGO – July 15, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce, has issued the following letter to shareholders. To our Shareholders: Last December, I authored a shareholder letter which referenced the...
-
Interview with Mr. Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc. Discusses the Potential of Future Partners or Acquisition
Friday, July 15, 2011 - 12:16pm | 1783Point Roberts, WA, LINCOLNSHIRE, Ill – July 15, 2011 –(Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features an exclusive Q&A interview with Mr. Stephen M. Simes, President and Chief Executive...